Literature DB >> 18347618

The Boston Keratoprosthesis in severe ocular trauma.

Mona Harissi-Dagher1, Claes H Dohlman.   

Abstract

BACKGROUND: In eyes with corneal disease and opacity so severe that standard corneal transplantation carries a poor prognosis, a keratoprosthesis (KPro) may still be successful in providing functional visual acuity. The purpose of this study was to determine the outcome of Boston KPro implantation in the rehabilitation of severe ocular trauma.
METHODS: This is a retrospective study of 30 eyes (30 patients) with severe ocular trauma that underwent Boston KPro type I implantation at the Massachusetts Eye and Ear Infirmary. Of these 30 eyes, 6 had mechanical trauma, 21 had chemical burns, and 3 had thermal burns. The measures used in this review are 5-fold: (i) anatomic success; (ii) number of postoperative repair procedures performed; (iii) preoperative and postoperative visual acuity; (iv) number of eyes with concomitant preoperative retinal or optic nerve damage prior to KPro surgery; and (v) incidence of postoperative complications.
RESULTS: Preoperative visual acuity ranged from counting fingers to light perception (median: hand motion). Best-corrected postoperative visual acuity ranged from 20/20 to no light perception (median: 20/80). Anatomic success was achieved in 5 out of 5 mechanically traumatized eyes, 14 out of 17 eyes with chemical burns, and 3 out of 3 eyes with thermal burns. Repair procedures were done in 8 of the 17 chemically burned eyes. The number of eyes with concomitant preoperative ocular disease was 2 out of 6 in the mechanical trauma group, 10 out of 21 in the chemical burn group, and 1 out of 3 in the thermal burn group. The incidence of postoperative complications was greater in the chemical burn group than in either the mechanical trauma or the thermal burn group.
INTERPRETATION: The Boston KPro can provide considerable visual improvement and a long-term anatomic retention rate in severely traumatized eyes. The overwhelming danger in severe chemical burns is glaucoma progression despite a functioning tube implant and normal intraocular pressure.

Entities:  

Mesh:

Year:  2008        PMID: 18347618     DOI: 10.3129/i08-009

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  17 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Masako Chen; Sueko M Ng; Esen K Akpek; Sumayya Ahmad
Journal:  Cochrane Database Syst Rev       Date:  2020-05-13

3.  [Simulation of corneal epithelial injuries by mechanical and corrosive damage : Influence of fetal bovine serum and dexpanthenol on epithelial regeneration in a cell culture model].

Authors:  M Hahne; S Reichl
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

Review 4.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Esen K Akpek; Majed Alkharashi; Frank S Hwang; Sueko M Ng; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2014-11-05

Review 5.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

6.  Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes.

Authors:  Maria Stephanie R Jardeleza; Marc-Andre Rheaume; James Chodosh; Anne Marie Lane; Claes H Dohlman
Journal:  Digit J Ophthalmol       Date:  2015-12-21

7.  Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).

Authors:  Esen K Akpek; Sandra D Cassard; Karen Dunlap; Sarah Hahn; Pradeep Y Ramulu
Journal:  Trans Am Ophthalmol Soc       Date:  2015

8.  Epithelial growth over the optic surface of the type 1 Boston Keratoprosthesis: histopathology and implications for biointegration.

Authors:  Yousuf M Khalifa; Don Davis; Nick Mamalis; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2010-10-05

9.  Outcomes of the Boston keratoprosthesis in jordan.

Authors:  Wisam A Shihadeh; Hasan M Mohidat
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

10.  Short-term outcome of Boston Type 1 keratoprosthesis for bilateral limbal stem cell deficiency.

Authors:  Sayan Basu; Mukesh Taneja; Raja Narayanan; Sirisha Senthil; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.